# Peraso Inc.: Form 10-Q for the period ended Jun 30, 2013

- Company: [Peraso Inc.](/companies/prso.md) (CIK 890394)
- Form: 10-Q
- Filed: 2013-08-08
- Accepted by EDGAR: Aug 8, 2013, 12:43 ET
- Period: 2013-06-30
- Accession: 0001104659-13-061552
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/890394/000110465913061552/a13-13816_110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/890394/000110465913061552/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2013-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2013-04-01 to 2013-06-30 | $1.1m | us-gaap:SalesRevenueNet |
| Revenue | 6 months, 2013-01-01 to 2013-06-30 | $2.5m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2013-04-01 to 2013-06-30 | $77.0k | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2013-01-01 to 2013-06-30 | $96.0k | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2013-04-01 to 2013-06-30 | $1.0m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2013-01-01 to 2013-06-30 | $2.4m | us-gaap:GrossProfit |
| Research and development | 3 months, 2013-04-01 to 2013-06-30 | $6.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2013-01-01 to 2013-06-30 | $11.3m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2013-04-01 to 2013-06-30 | $1.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2013-01-01 to 2013-06-30 | $3.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2013-04-01 to 2013-06-30 | −$6.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2013-01-01 to 2013-06-30 | −$11.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2013-04-01 to 2013-06-30 | $20.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2013-01-01 to 2013-06-30 | $40.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2013-04-01 to 2013-06-30 | −$6.4m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Net income | 6 months, 2013-01-01 to 2013-06-30 | −$11.4m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Diluted EPS | 3 months, 2013-04-01 to 2013-06-30 | −$0.15 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months, 2013-01-01 to 2013-06-30 | −$0.27 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 6 months, 2013-01-01 to 2013-06-30 | −$11.5m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 6 months, 2013-01-01 to 2013-06-30 | $84.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2013-06-30 | $8.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2013-06-30 | $41.7m | us-gaap:AssetsCurrent |
| Total assets | at 2013-06-30 | $87.0m | us-gaap:Assets |
| Current liabilities | at 2013-06-30 | $2.8m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2013-06-30 | $84.0m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 22,384 characters.

*This Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the accompanying condensed consolidated financial statements and notes included in this report. This Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which include, without limitation, statements about the market for our technology, our strategy, competition, expected financial performance, all information disclosed under Item 3 of this Part I, and other aspects of our business identified in our most recent annual report on Form 10-K filed with the Securities and Exchange Commission on March 12, 2013 and in other reports that we file from time to time with the Securities and Exchange Commission. Any statements about our business, financial results, financial condition and operations contained in this Form 10-Q that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words “believes,” “anticipates,” “expects,” “intends,” “plans,” “projects,” or similar expressions are intended to identify forward-looking statements. Our actual results could differ materially from those expressed or implied by these forward-looking statements as a result of various factors, including the risk factors described below in Risk Factors and elsewhere in this report and under Item 1A of our annual report on Form 10-K for the year ended December 31, 2012. We undertake no obligation to update publicly any forward-looking statements for any reason, except as required by law, even as new information becomes available or events occur in the future.*

### Company Overview

Our strategy and primary business objective is to become a fabless semiconductor company focused on the development and sale of integrated circuits, or ICs, for the high-speed networking, communications, storage and computing markets. Our technology delivers time-to-market, performance, power and economic benefits for system original equipment manufacturers, or OEMs. We have developed a family of ICs, called Bandwidth Engine, which combines our proprietary 1T-SRAM high-density embedded memory and high-speed serial interface, or SerDes, I/O, with our intelligent access technology and a highly efficient interface protocol. In March 2013, we announced another IC product line under the “LineSpeed” product name. LineSpeed ICs are non-memory, high-speed SerDes I/O devices with gearbox and retimer functionality, which convert lanes of data received on line cards into different configurations and/or ensure signal integrity. We developed this product family under a strategic development and marketing agreement with Credo Semiconductor Ltd., or Credo. Under this agreement, the first $1.2 million of gross profits generated by us or Credo from the sale of these products will be paid to us as reimbursement of the development costs. Thereafter, all gross profits from the sale of these LineSpeed products worldwide will be shared equally by Credo and us.

Historically, our primary business was the design, development, marketing, sale and support of differentiated intellectual property, or IP, including embedded memory and high-speed parallel and SerDes I/O used in advanced systems-on-chips, or SoCs. Since the beginning of 2010, we have invested an increasing amount of our research and development resources towards development of our IC products. Our future success and ability to achieve and maintain profitability will be dependent on the marketing and sales of our IC products into networking, communications and other markets requiring high performance. During 2011, we began placing less emphasis on IP licensing and deploying more resources towards our IC product development and marketing efforts. We have been focused on monetizing our IP portfolio to fund the change in our business. Towards this end, we have completed asset sales for proceeds of approximately $39.3 million, including our December 2011 patent sale and March 2012 SerDes technology sale. We are using the proceeds from these sales to partially fund our investment in our IC products. We still maintain a large patent portfolio with over 100 patents granted and pending with more in process.

Revenue from IP licensing and royalties represented the majority of our revenues for 2012, and we expect revenue from IP licensing and royalties to continue to represent the majority of our revenues in 2013. As a result of our reduced licensing activities, we expect our licensing and royalty revenue to decrease in future periods. Our expectation is that over time our revenue will transition from primarily licensing and royalty to predominately IC product sales. To date, we have not generated significant revenue from sales of our IC products. We are currently supporting existing design-win customers and actively pursuing additional design wins for the use of our ICs in networking and communication equipment. Based on our current expense levels and assumptions about future IC product revenue, we believe we would need IC product revenues of approximately $14 million per quarter to achieve positive cash flows. However, this is only an estimate and is subject to potentially significant changes in our future operations and material variations in operating expense levels and other future expenditures, as described below under “—*Liquidity and Capital Resources; Changes in Financial Condition.”*

### Sources of Revenue

*Licensing.* Licensing revenue consists of fees earned from license agreements, development services, prepaid pre-production royalties, and support and maintenance. Our licensing revenue consists primarily of fees for providing circuit design, layout and design verification and granting licenses to customers that embed our technology into their products. The vast majority of our contracts allow for milestone billing based on work performed. Fees billed prior to revenue recognition are recorded as deferred revenue.

*Royalty.* Royalty revenue represents amounts earned under provisions in our memory licensing contracts that require our licensees to report royalties and make payments at a stated rate based on actual units manufactured or sold by licensees for products that include our memory IP. Our license agreements require the licensee to report the manufacture or sale of products that include our technology after the end of the quarter in which the sale or manufacture occurs, and we recognize royalties in the quarter in which we receive the licensee’s report.

The timing and level of royalties are difficult to predict. They depend on the licensee’s ability to market, produce and sell products incorporating our technology. Many of the products of our licensees that are currently subject to licenses from us are used in consumer products, such as electronic game consoles, for which demand can be seasonal.

*IC product.* IC product revenue, which is included in licensing and other revenue, is generally recognized at the time of shipment to our customers. An estimated allowance is recorded, at the time of shipment, for future returns and other charges against revenue consistent with the terms of sale. IC product revenue and costs relating to sales made through distributors with rights of return and stock rotation are deferred until the distributors sell the product to end customers due to our inability to estimate future returns and credits to be issued. At the time of shipment to distributors, an accounts receivable for the selling price is recorded, as there is a legally enforceable right to receive payment, inventory is relieved, as legal title to the inventory is transferred upon shipment, and the associated deferred margin is recorded as deferred revenues in the condensed consolidated balance sheets. Revenues are recognized upon receiving notification from the distributors that products have been sold to end customers.

### Critical Accounting Policies and Estimates

The discussion and analysis of our financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of these financial statements requires us to make certain estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an ongoing basis we make these estimates based on our historical experience and on assumptions that we consider reasonable under the circumstances. Actual results may differ from these estimates, and reported results could differ under different assumptions or conditions. Our significant accounting policies and estimates are disclosed in Note 1 of the “Notes to Consolidated Financial Statements” in our Annual Report on Form 10-K for the year ended December 31, 2012. As of June 30, 2013, there have been no material changes to our significant accounting policies and estimates.

### Results of Operations

*Net Revenue.*

*(dollar amounts in thousands)*

|  | June 30, 2013 | 2012 | Change 2012 to 2013 |  |
| --- | ---: | ---: | ---: | ---: |
| Licensing and other — three months ended | $160 | $644 | $(484) | (75)% |
| Percentage of total net revenue | 14% | 37% |  |  |
| Licensing and other — six months ended | $409 | $865 | $(456) | (53)% |
| Percentage of total net revenue | 17% | 27% |  |  |

17

Licensing and other revenue decreased for the three and six months ended June 30, 2013, compared with the same periods of 2012, primarily due to the decline in the number and value of license agreements. We did not execute any new license agreements in the first half of 2013, and we do not expect to enter into new license agreements during the remainder of 2013. Revenue from the sale of our IC products was included in this line item, and was not considered significant for the three and six months ended June 30, 2013.

*(dollar amounts in thousands)*

|  | June 30, 2013 | 2012 | Change 2012 to 2013 |  |
| --- | ---: | ---: | ---: | ---: |
| Royalty — three months ended | $960 | $1,092 | $(132) | (12)% |
| Percentage of total net revenue | 86% | 63% |  |  |
| Royalty — six months ended | $2,046 | $2,295 | $(249) | (11)% |
| Percentage of total net revenue | 83% | 73% |  |  |

Royalty revenue decreased for the three and six months ended June 30, 2013, compared with the same periods of 2012, primarily due to a decrease in shipments by fabless semiconductor companies that incorporate our licensed IP, partially offset by an increase in royalties received from a major foundry partner.

#### Cost of Net Revenue and Gross Profit.

*(dollar amounts in thousands)*

|  | June 30, 2013 | 2012 | Change 2012 to 2013 |  |
| --- | ---: | ---: | ---: | ---: |
| Cost of net revenue — three months ended | $77 | $179 | $(102) | (57)% |
| Percentage of total net revenue | 7% | 10% |  |  |
| Cost of net revenue — six months ended | $96 | $236 | $(140) | (59)% |
| Percentage of total net revenue | 4% | 7% |  |  |

*(dollar amounts in thousands)*

|  | June 30, 2013 | 2012 | Change 2012 to 2013 |  |
| --- | ---: | ---: | ---: | ---: |
| Gross profit — three months ended | $1,043 | $1,557 | $(514) | (33)% |
| Percentage of total net revenue | 93% | 90% |  |  |
| Gross profit — six months ended | $2,359 | $2,924 | $(565) | (19)% |
| Percentage of total net revenue | 96% | 93% |  |  |

Cost of net revenue consists of personnel and related overhead allocation costs for engineers assigned to revenue-generating licensing arrangements and direct and indirect costs related to the sale of IC products.

Cost of net revenue decreased for the three and six months ended June 30, 2013, compared with the same periods of 2012, primarily due to the lack of new licensing agreements and limited engineering services required on existing contracts. Cost of net revenue included stock-based compensation expense of $5,000 and $38,000 for the three months ended June 30, 2013 and 2012, respectively, and $7,000 and $46,000 for the six months ended June 30, 2013 and 2012, respectively.

Gross profit decreased for the three and six months ended June 30, 2013, compared with the same periods of 2012, primarily due to the decrease in our revenue. Gross margin percentage increased for the three and six months ended June 30, 2013, compared with the same periods of 2012, primarily due to less engineering services required on existing contracts.

#### Research and Development.

*(dollar amounts in thousands)*

|  | June 30, 2013 | 2012 | Change 2012 to 2013 |  |
| --- | ---: | ---: | ---: | ---: |
| Research and development — three months ended | $5,983 | $6,688 | $(705) | (11)% |
| Percentage of total net revenue | 534% | 385% |  |  |
| Research and development — six months ended | $11,303 | $14,194 | $(2,891) | (20)% |
| Percentage of total net revenue | 460% | 449% |  |  |

Our research and development expenses include costs related to the development of our IC products and amortization of intangible assets. We expense research and development costs as they are incurred.

The $0.7 million decrease for the three months ended June 30, 2013, compared with the same period a year ago, was primarily due to lower personnel costs resulting from lower headcount and reduced amortization costs related to intangible assets, partially offset by increased development costs related to the development of our Bandwidth Engine IC products.

Research and development expenses included stock-based compensation expense of $0.7 million for each of the three months ended June 30, 2013 and 2012.

The $2.9 million decrease for the six months ended June 30, 2013, compared with the same period a year ago, was primarily due to lower personnel costs resulting from lower headcount and reduced amortization costs related to intangible assets and computer-aided software tools costs, partially offset by increased development costs related to the development of our Bandwidth Engine IC products.

Research and development expenses included stock-based compensation expense of $1.3 million and $1.5 million for the six months ended June 30, 2013 and 2012, respectively.

#### Selling, General and Administrative (SG&A).

*(dollar amounts in thousands)*

|  | June 30, 2013 | 2012 | Change 2012 to 2013 |  |
| --- | ---: | ---: | ---: | ---: |
| SG&A — three months ended | $1,460 | $1,428 | $32 | 2% |
| Percentage of total net revenue | 130% | 82% |  |  |
| SG&A — six months ended | $3,083 | $4,354 | $(1,271) | (29)% |
| Percentage of total net revenue | 126% | 138% |  |  |

Selling, general and administrative expenses consist primarily of personnel and related overhead costs for sales, marketing, finance, human resources and general management.

Selling, general and administrative expenses remained consistent for the three months ended June 30, 2013, compared with the same period a year ago, as a result of lower personnel costs, offset by higher legal costs.

Selling, general and administrative expenses for the six months ended June 30, 2013 were 29% lower, compared with the same period a year ago, primarily because the comparable period of 2012 included a $0.6 million arbitration judgment and related legal fees incurred in the first quarter of 2012.

Selling, general and administrative expenses included stock-based compensation expense of $0.2 million and $0.3 million for the three months ended June 30, 2013 and 2012, respectively. Selling, general and administrative expenses included stock-based compensation expense of $0.5 million for each of the six months ended June 30, 2013 and 2012.

We expect total selling, general and administrative expenses to remain flat in absolute dollars for the remainder of 2013.

#### Other Income and Expense, net.

*(dollar amounts in thousands)*

|  | June 30, 2013 | 2012 | Change 2012 to 2013 |  |
| --- | ---: | ---: | ---: | ---: |
| Other income and expense, net — three months ended | $24 | $36 | $(12) | (33)% |
| Percentage of total net revenue | 2% | 2% |  |  |
| Other income and expense, net — six months ended | $44 | $60 | $(16) | (27)% |
| Percentage of total net revenue | 2% | 2% |  |  |

Other income and expense, net primarily consisted of interest income on our investments, offset by expenses, including foreign exchange transaction losses and other non-operating expenses.

#### Income Tax Provision.

*(dollar amounts in thousands)*

|  | June 30, 2013 | 2012 | Change 2012 to 2013 |  |
| --- | ---: | ---: | ---: | ---: |
| Income tax provision — three months ended | $20 | $30 | $(10) | (33)% |
| Percentage of total net revenue | 2% | 2% |  |  |
| Income tax provision — six months ended | $40 | $60 | $(20) | (33)% |
| Percentage of total net revenue | 2% | 2% |  |  |

The provision for the three and six months ended June 30, 2013 and 2012 was attributable to taxes on earnings of our foreign subsidiaries and branches. We believe that, based on the history of our operating losses and other factors, the weight of available evidence indicates that it is more likely than not that we will not be able to realize the benefit of our net operating losses. Accordingly, a full valuation reserve has been recorded against our net deferred tax assets.

### Liquidity and Capital Resources; Changes in Financial Condition

#### Cash Flows

As of June 30, 2013, we had cash, cash equivalents and short and long-term investments of $58.9 million and had total working capital of $38.9 million. In the second quarter of 2013, we recorded $27.9 million in net proceeds from the sale of 7.5 million shares of our common stock in a public offering. Our primary capital requirements are to fund working capital, including development of our IC products, and any acquisitions that we make that require cash considerations or expenditures.

Net cash used in operating activities was $11.5 million for the first six months of 2013, which primarily resulted from the net loss of $11.4 million, a gain on sale of assets of $0.6 million and $2.2 million in the net reduction of assets and liabilities, partially offset by non-cash charges, including stock-based compensation expense of $1.8 million and depreciation and amortization expenses of $0.9 million. The changes in assets and liabilities primarily related to the timing of collection of receivables from customers and payments to vendors.

Net cash used in operating activities was $11.2 million for the first six months of 2012, which primarily resulted from the net loss of $13.8 million, increased by the $1.9 million gain on the sale of assets and adjusted for non-cash charges consisting of stock-based compensation of $2.1 million and depreciation and amortization of $1.7 million. The changes in assets and liabilities primarily related to the timing of billing our customers, collection of receivables and payments to vendors.

Net cash used in investing activities was $12.1 million for the first six months of 2013, and included net amounts transferred from cash and cash equivalents to investments of $12.7 million that did not impact our liquidity and $0.1 million for purchases of fixed assets, partially offset by $0.6 million in proceeds from the sale of assets.

Net cash used in investing activities was $24.9 million for the first six months of 2012, and included net amounts transferred from cash to marketable securities of $27.0 million that did not impact our liquidity and $2.2 million in proceeds from the sale of SerDes technology in March 2012.

Our proceeds from financing activities for the first six months of 2013 of $29.2 million consisted primarily of net proceeds received from the sale of common stock though a public offering and proceeds from the exercise of stock options and purchases of common stock under our employee stock purchase plan. Our financing activities for the first six months of 2012 primarily consisted of proceeds from the exercise of stock options and sales under our employee stock purchase plan, offset by a payment made to repurchase shares of common stock to comply with an arbitration judgment.

Our future liquidity and capital requirements are expected to vary from quarter to quarter, depending on numerous factors, including:

- level of revenue;
- cost, timing and success of technology development efforts, including meeting customer design specifications;
- fabrication costs, including mask costs of our ICs, currently under development;
- variations in manufacturing yields, materials costs and other manufacturing risks;
- costs of acquiring other businesses and integrating the acquired operations; and
- profitability of our business.

We expect our cash expenditures to continue to exceed receipts in 2013 by $15 million to $18 million as our revenues will not be sufficient to offset our operating expenses, which include significant research and development expenditures for the expansion and fabrication of our IC products. We believe our existing cash, cash equivalents and investments, along with our existing capital and cash generated from operations, if any, to be sufficient to meet our capital requirements for the foreseeable future. There can be no assurance that our capital is sufficient to fund operations until such time as we begin to achieve positive cash flows. We might decide to raise additional capital, and there can be no assurance that such funding will be available to us on favorable terms, if at all. The failure to raise capital when needed could have a material adverse effect on our business and financial condition.

### Contractual Obligations

The impact that our contractual obligations as of June 30, 2013 are expected to have on our liquidity and cash flow in future periods is as follows (in thousands):

|  | Payment Due by Period Total | Less than 1 year | 1-3 years | 3-5 years | More than 5 years |
| --- | ---: | ---: | ---: | ---: | ---: |
| Operating Leases | $5,351 | $761 | $1,457 | $1,493 | $1,640 |
| Purchase Commitments | 6,903 | 2,636 | 4,267 | — | — |
|  | $12,254 | $3,397 | $5,724 | $1,493 | $1,640 |

As of June 30, 2013, our purchase commitments were for licenses related to computer-aided design tools payable through 2016. Purchase commitments increased $3.6 million from March 31, 2013 primarily due to the renewal of our computer-aided design tool licenses.

## Market risk

As filed, 988 characters.

Our investment portfolio consists of money market accounts, certificates of deposit, corporate debt, government agency and municipal debt securities. The portfolio dollar-weighted average maturity of these investments is within 12 months. Our primary objective with this investment portfolio is to invest available cash while preserving principal and meeting liquidity needs. No single security should exceed 5% of the portfolio or $2.0 million at the time of purchase. In accordance with our investment policy, we place investments with high credit quality issuers and limit the amount of credit exposure to any one issuer. These securities, which approximated $54.2 million as of June 30, 2013 and earned an average annual interest rate of approximately 0.2% during the first six months of 2013, are subject to interest rate and credit risks. We do not have any investments denominated in foreign currencies, and, therefore, are not subject to foreign currency risk on such investments.

## Controls and procedures

As filed, 1,277 characters.

*Disclosure Controls and Procedures.* Our management is responsible for establishing and maintaining adequate internal control over our financial reporting. Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934. Based on this evaluation, our management concluded that as of June 30, 2013, our disclosure controls and procedures were effective.

*Changes in Internal Control over Financial Reporting.* During the second quarter of 2013, there was no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 548 characters.

We face many significant risks in our business, some of which are unknown to us and not presently foreseen. These risks could have a material adverse impact on our business, financial condition and results of operations in the future. We have disclosed a number of material risks under Item 1A of our annual report on Form 10-K for the year ended December 31, 2012, which we filed with the Securities and Exchange Commission on March 12, 2013, as amended by a Form 10-K/A, which we filed with the Securities and Exchange Commission on May 14, 2013.

Filed Aug 8, 2013.
Source: SEC EDGAR, the filing index for accession 0001104659-13-061552. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
